Skip to Content
Stock Analyst Update

IBM’s Q1 Sees Break From Mainframe Cyclicality

Market volatility and security concerns increased mainframe capacity needs, leading to nearly 50% year-over-year growth in the seventh quarter since the z15 model’s launch.

Mentioned:

 

IBM’s (IBM) first quarter results came in above our expectations as its consulting business started to pick up--and its z15 mainframes unexpectedly took a turn for the better--breaking from expected market cyclicality. Market volatility and security concerns increased mainframe capacity needs, leading to nearly 50% year-over-year growth in the seventh quarter since the z15 model’s launch. Despite the impressive breach of typical trends, IBM doesn’t expect such anomalous activity in the smaller systems segment to continue--as it reiterates guidance for 2021 which includes revenue growth. We think top-line growth is feasible due to the easy compare from a hard-hit 2020 as well as our belief that global business services, which is now growing, is a harbinger for recovery throughout the rest of the business. All in all, we’re maintaining our fair value estimate of $125 per share for the narrow-moat IT services provider, which leaves the company fairly valued.

IBM reported revenue of $17.7 billion in the quarter, marking a 1% year-over-year increase. Cloud and cognitive, and systems tied for the best performing segments, both reporting revenue growth of 4% year over year. In the former segment, Cloud Paks software saw robust growth. In the latter, much smaller segment, the z15 mainframe broke from expected cyclicality, driven by increased market volatility and security concerns that caused a flock to mainframes. Mainframe revenues grew by 49% year over year off an incredibly difficult comparison of 60% growth in the prior year period. The global business services segment returned to year-over-year revenue growth, increasing by 2%, due to consulting services seeing a recovery. However, the global financing division continued to suffer the worst performance, with revenue down by 20% year over year. Yet, the significant decline is a result of IBM’s conscious decision to reduce financing receivables.

 

Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.

Julie Bhusal Sharma does not own shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.